Table 2. Functional and clinical characteristics of study patients at one month follow-up visit.
| Variables | Total |
|---|---|
| (n = 102) | |
| Cardiac symptoms, No. (%) | |
| Yes | 41 (40.20) |
| • dyspnea | 28 (27) |
| • palpitations | 12 (12) |
| • chest pain | 8 (8) |
| • syncope | 5 (5) |
| No | 61 (59.80) |
| Spirometry | |
| • FEV1% predicted | 103.31±15.53 |
| • FVC % predicted | 107 [96.5–118] |
| • FEV1/FVC (%) | 78 [73.25–81] |
| METs Physical Performance | 6.03 [5.50–6.53] |
| HADS-A score | 3 [1–6] |
| HADS-D score | 2 [1–5] |
| Days of hospitalization | 4 [4–6] |
| Sickness absence days | 44 [33–88] |
Data are expressed as mean ± standard deviation or median [interquartile ranges: 25th-75th percentile] or number of subjects (%). FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity; HADS-A score: score of anxiety subscale of the Hospital Anxiety and Depression Scale; HADS-D score: score of depression subscale of the Hospital Anxiety and Depression Scale; MET: metabolic equivalent.